| 产品类别 | 2025 年 1-6 月 | | 2024 年 | | 2023 年 | | 2022 年 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 金额 | 比例 | 金额 | 比例 | 金额 | 比例 | 金额 | 比例 | | 抗溢胶特种膜 | 16, 417. 96 | 52. 43% | 33, 482. 25 | 50.97% | 27,652.01 | 53. 60% | 30. 564. 98 | 67. 16% | | 强耐受性特种膜 | 7,272.05 | 23. 22% | 14.995.76 | 22.83% | 11,787.65 | 22. 85% | 11.909.86 | 26. 17% | | 新能源材料 | 3,941.97 | 12. 59% | 9,690. 41 | 14.75% | 4.435.23 | 8.60% | 134.61 | 0. 30% | | 光学胶膜 | 906. 95 | 2. 90% | 2.369.42 | 3.61% | 1.744.39 | 3.38 ...

经新广益和主承销商协商一致，将拟申购价格高于22.54元/股（不含）的配售对象全部剔除；拟申购价格为22.54元/股、拟申购数量为1000万股且申购 时间为2025年12月16日14:07:27:757的配售对象中，按照网下发行电子平台自动生成的委托序号从后往前排列剔除9个配售对象。以上过程共剔除92个 配售对象。 日前，苏州市新广益电子股份有限公司（以下简称为"新广益"）披露了发行公告，确定创业板上市发行价21.93元/股，发行市盈率为28.59倍，而该公 司所在行业最近一个月平均静态市盈率为57.92倍。12月22日，该公司将开启网上网下申购。 新广益保荐人（主承销商）为中信证券。网下询价期间，主承销商通过深交所网下申购电子平台共收到310家网下投资者管理的8885个配售对象的初 步询价报价信息，报价区间为20.05元/股-26.53元/股。 报价信息表显示，网下询价中，衍盛私募证券投资基金管理（海南）有限公司管理的5只产品报出20.05元/股的最低价；上海汐泰投资管理有限公司管 理的5只产品报出26.53元/股的最高价，因报价过高被剔除。 | 投资者名称 | 配售对象名称 | 拟申购价格 | 拟申购数量 ...

智通财经APP讯，新广益(301687.SZ)发布首次公开发行股票并在创业板上市招股意向书，本次公开发行 股份数量为3671.6万股，占发行后总股本的25.00%。本次发行股份均为公开发行的新股，公司原有股东 不公开发售股份。初步询价日期为2025年12月16日，申购日期为2025年12月22日。 本次向社会公众公开发行新股的募集资金扣除发行费用后，将投资于功能性材料项目，拟使用募集资金 6.38亿元。 新广益是一家专注于高性能特种功能材料研发、生产及销售的高新技术企业，主要产品有抗溢胶特种 膜、强耐受性特种膜等特种功能材料。抗溢胶特种膜是一种用于柔性线路板生产过程中的重要制程材 料。强耐受性特种膜是一种应用于高洁净、高温、高湿、强酸碱、强外部应力等一种或多种极端恶劣生 产环境下的粘性材料。除抗溢胶特种膜、强耐受性特种膜外，公司还生产、研发并开展电子产品组件材 料、改性材料、光学胶膜、新能源锂电材料、光伏胶膜等新兴业务。 报告期各期，公司的主营业务收入分别为4.55亿元、5.16亿元、6.57亿元、3.13亿元，净利润分别为 8,151.34万元、8,328.25万元、11,570.19万元、5,920.58 ...

Core Viewpoint - Suzhou Xinguangyi Electronics Co., Ltd. has received approval for its IPO application, moving closer to listing on the A-share market, with plans to raise 638 million yuan for functional materials projects [1][2]. Group 1: IPO Process and Fundraising - The IPO journey of Xinguangyi took over two years, from application acceptance in June 2023 to receiving registration approval in October 2025 [2]. - The company plans to issue no more than 10 million ordinary shares, with the raised funds directed towards functional materials projects [2]. - The initial fundraising plan included 800 million yuan, with 500 million yuan allocated for functional materials and 300 million yuan for new energy lithium battery materials, but the latter was removed in the final plan [15][17]. Group 2: Financial Performance - Xinguangyi reported revenues of 455 million yuan, 516 million yuan, 657 million yuan, and 313 million yuan for the years 2022, 2023, 2024, and the first half of 2025, respectively, with a compound annual growth rate of approximately 20.15% from 2022 to 2024 [4]. - The net profit for the same periods was 81.51 million yuan, 83.28 million yuan, 116 million yuan, and 59.21 million yuan, showing steady growth [5]. - The company’s gross profit margins fluctuated, with rates of 31.74%, 32%, 32.27%, and 31.36% during the reporting periods [6]. Group 3: Market Position and Product Development - Xinguangyi holds the top market share in the anti-overflow special film segment in China, with a 30% market share projected for 2024 [4]. - The company has developed over 40 types of special functional films and coatings, with 15 core technologies and 38 invention patents [10]. - The R&D expenses have been increasing, with amounts of 22.33 million yuan, 27.62 million yuan, 31.04 million yuan, and 14.17 million yuan reported for the respective years [11]. Group 4: Challenges and Concerns - The company faces scrutiny regarding its performance metrics, R&D expenses, and the rationale behind its significant cash dividend of 220 million yuan prior to its IPO application [3][19]. - Xinguangyi's capacity utilization rates have shown variability, with rates of 79.73%, 75.52%, 99.64%, and 90.18% during the reporting periods, raising questions about operational sustainability [16][17]. - The company’s R&D expense ratio is lower than that of peers, attributed to limited financing channels and a smaller capital scale [13][14].